3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Etoposide
2
liposomal doxorubicin
1
dehydroftorafur
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
Zidovudine
1
Vincristine
1
Valganciclovir
1
Standard of Care
1
Sirolimus
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Rituximab
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Prednisone
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Mitozytrex
1
Mitomycin
1
Melphalan
1
Interferon-alpha
1
Health Promotion
1
Granulocyte Colony-Stimulating Factor
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HIV Infections
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.